| Arsenic Trioxide studied in …STUDIED_INderived113 of 113show fewer |
|---|
| → studied in | NCT07737769Phase 1 · not yet recruiting Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome · 113 trials list this drug (13 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02688140Phase 3 · completed Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia · 113 trials list this drug (13 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01409161Phase 2 · recruiting Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia · 113 trials list this drug (13 active) | — | — | Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07503730Phase 3 · recruiting Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL). · 113 trials list this drug (13 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02339740Phase 3 · active not recruiting Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia · 113 trials list this drug (13 active) | — | — | Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07348107Phase 1 · not yet recruiting ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma. · 113 trials list this drug (13 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07296445Phase 3 · not yet recruiting A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301) · 113 trials list this drug (13 active) | — | — | Leukemia,Acute Leukemia,Acute Promyelocytic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07187505NA · active not recruiting Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic Leukemia · 113 trials list this drug (13 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06778187Phase 2 · recruiting Oral-ATO for TP53-mutated Myeloid Malignancies · 113 trials list this drug (13 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03031249Phase 1/Phase 2 · enrolling by invitation Efficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid Leukemia · 113 trials list this drug (13 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03503864Phase 2 · active not recruiting Phase II Study of Combined Chemotherapy With Arsenic Trioxide in Stage 4/M Neuroblastoma · 113 trials list this drug (13 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06933394Phase 2 · recruiting Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma · 113 trials list this drug (13 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04793919Phase 2 · recruiting Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia · 113 trials list this drug (13 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04996030Phase 1 · suspended A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia · 113 trials list this drug (13 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06088030Phase 2 · recruiting Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer · 113 trials list this drug (13 active) | — | — | Childhood Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00551460Phase 2 · completed S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia · 113 trials list this drug (13 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03855371Phase 1 · unknown Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS · 113 trials list this drug (13 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05497310Phase 1/Phase 2 · unknown Effectiveness and Safety of Therapy Based on Attenuated ATO Plus Low-Dose ATRA in Patients With APL · 113 trials list this drug (13 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00866918Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia · 113 trials list this drug (13 active) | — | — | Myeloid Neoplasm,Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00482833Phase 3 · completed Phase III Trial in Acute Promyelocytic Leukemia Patients · 113 trials list this drug (13 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01014546Phase 1 · terminated Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis · 113 trials list this drug (13 active) | — | — | Essential Thrombocythemia,Polycythemia Vera,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02200978Phase 4 · completed A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia · 113 trials list this drug (13 active) | — | — | Childhood Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05297123Phase 1 · unknown Treatment of Acute Myeloid Leukemia With Arsenic and All-trans Retinoid Acid · 113 trials list this drug (13 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03751917unknown Long-term Safety Study of Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk Acute Promyelocytic Leukemia · 113 trials list this drug (13 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02899169Phase 3 · unknown Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF) · 113 trials list this drug (13 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02190695Phase 2 · completed Leukemia SPORE Phase II DAC Study for R/R and Elderly Acute AML and MDS · 113 trials list this drug (13 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04869475Phase 2 · unknown Arsenic Trioxide in Refractory Solid Tumors With Rescuable p53 Mutation · 113 trials list this drug (13 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01470248Phase 2 · completed Study of Arsenic Trioxide in Small Cell Lung Cancer · 113 trials list this drug (13 active) | — | — | Malignant Lung Neoplasm,Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04695223Phase 2 · unknown Arsenic Trioxide for Structural p53 Mutations · 113 trials list this drug (13 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02699723early Phase 1 · withdrawn Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer · 113 trials list this drug (13 active) | — | — | Skin Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00017433Phase 2 · terminated Arsenic Trioxide in Treating Patients With Multiple Myeloma · 113 trials list this drug (13 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00017069Phase 2 · terminated Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma · 113 trials list this drug (13 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00020969Phase 2 · terminated Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes · 113 trials list this drug (13 active) | — | — | Leukemia,Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00469209Phase 1/Phase 2 · completed Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients · 113 trials list this drug (13 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00234000Phase 1 · terminated Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes · 113 trials list this drug (13 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04489706NA · unknown Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation · 113 trials list this drug (13 active) | — | — | Malignant Ovarian Neoplasm,Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00274820Phase 2 · completed Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder · 113 trials list this drug (13 active) | — | — | Leukemia,Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00275067Phase 1/Phase 2 · unknown Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery · 113 trials list this drug (13 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00571116Phase 1 · terminated Disulfiram Plus Arsenic Trioxide In Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy · 113 trials list this drug (13 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00413166Phase 2 · completed All-trans Retinoic Acid, and Arsenic +/- Idarubicin · 113 trials list this drug (13 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006091Phase 2 · withdrawn Arsenic Trioxide in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Has Not Responded to Previous Treatment · 113 trials list this drug (13 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01397734Phase 1 · terminated Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML) · 113 trials list this drug (13 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004149Phase 2 · completed Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy · 113 trials list this drug (13 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00104806Phase 2 · terminated Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes · 113 trials list this drug (13 active) | — | — | Leukemia,Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01791894Phase 1/Phase 2 · completed Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma · 113 trials list this drug (13 active) | — | — | Malignant Skin Neoplasm,Skin Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01835288Phase 2 · withdrawn Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 113 trials list this drug (13 active) | — | — | Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia with Maturation+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118196Phase 2 · terminated Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia · 113 trials list this drug (13 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03381781Phase 2 · unknown Decitabine,Cytarabine and Arsenic Trioxide for Acute Myeloid Leukemia With p53 Mutations · 113 trials list this drug (13 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01428128Phase 2 · completed Low Dose Arsenic Trioxide as a Potential Chemotherapy Protector · 113 trials list this drug (13 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01184053Phase 2 · terminated Trisenox® in Women With Metastatic Endometrial Cancer · 113 trials list this drug (13 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00128596Phase 2 · completed Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery · 113 trials list this drug (13 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00195104Phase 1/Phase 2 · completed Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AML · 113 trials list this drug (13 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02956772Phase 2 · unknown Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients · 113 trials list this drug (13 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006021Phase 1/Phase 2 · completed Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma · 113 trials list this drug (13 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00449137Phase 1 · completed Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to Treatment · 113 trials list this drug (13 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00504101Phase 1 · withdrawn Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant For Multiple Myeloma · 113 trials list this drug (13 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00582400Phase 2 · terminated A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver · 113 trials list this drug (13 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00528450Phase 2 · terminated Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia · 113 trials list this drug (13 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00024258Phase 2 · completed Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors · 113 trials list this drug (13 active) | — | — | Childhood Germ Cell Tumor,Extragonadal Germ Cell Tumor,Sarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00670150Phase 2 · withdrawn New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia · 113 trials list this drug (13 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00075413Phase 2 · withdrawn Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer · 113 trials list this drug (13 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00274781Phase 2 · completed Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes · 113 trials list this drug (13 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00201695Phase 2 · completed Liposomal Doxorubicin, Vincristine, & Dexamethasone Plus Arsenic Trioxide in Untreated Symptomatic Multiple Myeloma · 113 trials list this drug (13 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00020111Phase 1 · completed Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma · 113 trials list this drug (13 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02066870Phase 1 · unknown Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI · 113 trials list this drug (13 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00504764Phase 4 · completed Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO) · 113 trials list this drug (13 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00184054Phase 2 · terminated Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia · 113 trials list this drug (13 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00276601Phase 2 · completed Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia · 113 trials list this drug (13 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093483Phase 1 · completed Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia · 113 trials list this drug (13 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003885Phase 2 · unknown Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma · 113 trials list this drug (13 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00985530Phase 1 · terminated Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia · 113 trials list this drug (13 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00053222Phase 2 · completed Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine · 113 trials list this drug (13 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454480Phase 2/Phase 3 · completed Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes · 113 trials list this drug (13 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085345Phase 2 · withdrawn Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma · 113 trials list this drug (13 active) | — | — | Multiple Myeloma,Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112879Phase 2 · withdrawn Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma · 113 trials list this drug (13 active) | — | — | Multiple Myeloma,Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003395Phase 1 · completed Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer · 113 trials list this drug (13 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003630Phase 1 · completed Arsenic Trioxide in Treating Patients With Advanced Solid Tumors · 113 trials list this drug (13 active) | — | — | Adult Solid Neoplasm,Childhood Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00036842Phase 2 · completed Arsenic Trioxide in Treating Men With Germ Cell Cancer · 113 trials list this drug (13 active) | — | — | Extragonadal Germ Cell Tumor,Testicular Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005618Phase 2 · completed Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia · 113 trials list this drug (13 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005999Phase 2 · completed Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer · 113 trials list this drug (13 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006008Phase 2 · completed Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia · 113 trials list this drug (13 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005040Phase 2 · completed Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma · 113 trials list this drug (13 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005069Phase 2 · completed Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer · 113 trials list this drug (13 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003934Phase 3 · completed Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia · 113 trials list this drug (13 active) | — | — | Adult Acute Myeloid Leukemia,Adult Acute Promyelocytic Leukemia,Childhood Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00081133Phase 1/Phase 2 · completed Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia · 113 trials list this drug (13 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01861912Phase 2/Phase 3 · unknown Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma · 113 trials list this drug (13 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00009867Phase 2 · completed Arsenic Trioxide in Treating Patients With Urothelial Cancer · 113 trials list this drug (13 active) | — | — | Malignant Ureter Neoplasm,Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00671697Phase 1 · completed Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia · 113 trials list this drug (13 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00258245Phase 1 · completed Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia · 113 trials list this drug (13 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00008697Phase 1/Phase 2 · completed Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia · 113 trials list this drug (13 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045565Phase 1 · completed Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma · 113 trials list this drug (13 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00661544Phase 1/Phase 2 · completed Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients · 113 trials list this drug (13 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00075426Phase 2 · completed Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer · 113 trials list this drug (13 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006220Phase 1/Phase 2 · terminated Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy · 113 trials list this drug (13 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005786NA · terminated Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia · 113 trials list this drug (13 active) | — | — | Non-Hodgkin Lymphoma,Chronic Lymphocytic Leukemia,Prolymphocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00061958Phase 2 · terminated Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction · 113 trials list this drug (13 active) | — | — | Malignant Esophageal Neoplasm,Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00016159Phase 2 · completed Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia · 113 trials list this drug (13 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00124605Phase 1 · completed Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma · 113 trials list this drug (13 active) | — | — | Adult Solid Neoplasm,Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006090Phase 2 · withdrawn Arsenic Trioxide in Treating Patients With Refractory or Relapsed Chronic Lymphocytic Leukemia · 113 trials list this drug (13 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006092Phase 2 · terminated Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia · 113 trials list this drug (13 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00513305Phase 3 · terminated Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia · 113 trials list this drug (13 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005595Phase 2 · terminated Arsenic Trioxide in Treating Patients With Relapsed or Refractory Hodgkin's Disease · 113 trials list this drug (13 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005795Phase 2 · completed Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia · 113 trials list this drug (13 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00053248Phase 1/Phase 2 · completed Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia · 113 trials list this drug (13 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00227682Phase 2 · terminated Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma · 113 trials list this drug (13 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093366Phase 1/Phase 2 · completed Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes · 113 trials list this drug (13 active) | — | — | Leukemia,Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00193518Phase 2 · completed Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma · 113 trials list this drug (13 active) | — | — | Chronic Lymphocytic Leukemia,Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095771Phase 1 · completed Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas · 113 trials list this drug (13 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720564Phase 1 · completed Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma · 113 trials list this drug (13 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00185861Phase 1 · completed Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma · 113 trials list this drug (13 active) | — | — | Malignant Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00850304Phase 2 · completed Treatment of Non Promyelocytic Acute Myeloid Leukaemia on Elderly Patients by Low Dose Cytosar Plus Arsenic Trioxide · 113 trials list this drug (13 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00193544Phase 2 · completed Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma · 113 trials list this drug (13 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00196768Phase 4 · unknown Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic · 113 trials list this drug (13 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |